Dr Gaétan Burgio.
banner
gaetanburgio.bsky.social
Dr Gaétan Burgio.
@gaetanburgio.bsky.social
Group leader, Australian National University (ANU), Australia. Interested in microbial infections & CRISPR gene editing. Opinions and views are my own. https://jcsmr.anu.edu.au/research/groups/burgio-group-genome-editing-and-microbial-immunity
Delighted to share our latest on #CRISPR In this paper we tried to determine the mechanisms of trans-cleavage activity of #CRISPR Cas12a enzymes, property used for molecular detection. Bottom line -> electrostatic interactions near the RuvC active site are critical.

www.biorxiv.org/content/10.1...
October 27, 2025 at 11:04 AM
Delighted to share our latest #preprint on Nanopore sequencing of the ssRNA MS2 #phage, which bits of the genome is heavily used in molecular biology and biotech. We though we knew all about MS2, well far from it. It is Incredible what a 3.6kb viral genome can do

www.biorxiv.org/content/10.1...
Nanopore direct RNA sequencing (DRS) of MS2 bacteriophages in E.coli throughout its life cycle reveals a complex transcriptional activity to control and maintain its growth
The RNA bacteriophage MS2 is a positive single stranded RNA phage that infects the bacterium E. coli and is one of the most crucial and representative model organisms in molecular biology and virology mimicking eukaryotic viruses. Previous research revealed translational control and feedback inhibitions in the MS2 life cycle. However, the dynamics of its transcriptional activity and replication during the life cycle within the bacteria is still relatively unknown. Here, we employed Nanopore Direct RNA sequencing (DRS) to investigate the transcriptome and epitranscriptome landscape of the MS2 in infected E. coli throughout its life cycle and detailed the dynamics of MS2 replication in real-time. We discovered that MS2 phages sustain a high level of transcriptional activity within the bacterial cell. We found large amounts of subgenomic small RNA transcripts containing the coat−encoding region. We found hybrid reads and mutations due to the error−prone activity of the MS2 replicase complex. We evidenced that RNA modification is conserved throughout the entire life cycle in full−length transcripts without the acquisition of new modifications whereas small transcripts did acquire and remove modified sites. The conserved sequence (5″−ΨU−3″) and secondary structure (stem-loops) of Ψ installation sites were the most amenable to RNA modification. Our investigation reveals a more complex transcriptional dynamics of MS2 phages within E. coli to maintain its growth and replicate under host pressure. ### Competing Interest Statement The authors have declared no competing interest.
www.biorxiv.org
April 2, 2025 at 9:00 PM
Happy to share our latest paper in collaboration with A/Prof Giulia Palermo's lab at UC Riverside on #CRISPR Cas12a cleavage. Here we describe 1/ Why CRISPR Cas12 orthologues are so different despite similar structure 2/ We focused on a specific part of the protein

www.biorxiv.org/content/10.1...
March 30, 2025 at 10:34 AM
Very interesting paper from Feng Zhang's group describing that the origin of #CRISPR RNA targeting system Cas13 is from the HEPN RNA-Toxin antitoxin system Abi-F. It also Assert that Cas13an described from the Doudna lab earlier this year is in fact a Cas13 intermediate. www.cell.com/cell/fulltex...
Reprogrammable RNA-targeting CRISPR systems evolved from RNA toxin-antitoxins
Hybrid structure-sequence mining and biochemical/structural characterization trace the evolutionary origins of CRISPR-Cas13, elucidating how their RNA-guided mechanism likely evolved from an ancient s...
www.cell.com
February 19, 2025 at 12:59 AM
Reposted by Dr Gaétan Burgio.
Interested in #malaria transmission and fertilisation? Check out our new work using cryo-EM of ENDOGENOUS sexual stage parasites to determine the Pfs230-Pfs48/45 fertilisation complex - please read & share!

structures| nanobodies |human immune responses | mRNA-LNP

www.biorxiv.org/content/10.1...
www.biorxiv.org
February 17, 2025 at 7:23 AM
Great to see this work from Gavin Knott's group out on the De novo design of #CRISPR Cas13 inhibitors aka (AIcrs) using RF-Diffusion. Great potency in inhibiting Cas13 nuclease.

www.biorxiv.org/content/10.1...
December 6, 2024 at 9:35 PM
Reposted by Dr Gaétan Burgio.
Very excited about the first preprint from our lab at TUM! This is a fun gene & cell therapy collaboration led by
@schmidts.bsky.social's lab. We use generative #AI
to design new #CARTcell therapies. Check out Andrea's thread & thanks to the whole team! www.biorxiv.org/content/10.1...
November 26, 2024 at 2:13 PM
Australian grants. Today was a big day with the release of the ARC outcomes rms.arc.gov.au/RMS/Report/D... & NHMRC ideas grants (under embargo). It has been a tough year with 10%!!!! success rate for NHMRC and 13%!!! for ARC DP (lowest ever success rate). Challenging to maintain a lab in Australia
Research Management System - Scheme Round Statistics for Approved Applications - Discovery Projects 2025 round 1
RMS is the ARC's Research Management System, a web-based system used by eligible researchers to prepare and submit research proposals and assessments under the ARC National Competitive Grants Program ...
rms.arc.gov.au
November 26, 2024 at 9:53 AM
After a long hiatus, I am now back on 🦋platform. Will keep doing what I used to do for a long time on the other platform. Looking very much forward interacting again with everyone on this platform.
November 26, 2024 at 9:44 AM